Bioman4r2 Banner
09/09/2024 | Online | 13:00 - 15:00 CEST (Amsterdam, Berlin, Paris)

Introduction combination product development

Location: Online

Bioman4r2 Banner

Sounds complicated? And what if my product is both?
Do not worry! In this webinar we will explain:

1.Why you need market approval
We will start by explaining the basic structure including the differences and similarities between CE marking and marketing authorization.

2.How do you determine which regulations are applicable to you as a manufacturer
Your device can never be a medical device AND a medicinal product. You need to choose which set of rules is applicable for your product. We will explain how to determine this.

3.What technical documentation you need
Once you have determined which rules are applicable, the rules prescribe which documents you need. We will give a short overview of the documentation required for medical devices and medicinal products.

4. Voyage to the new world
With an initial grasp of regulatory requirements in the EU and an idea of how to get started, we glimpse across the Atlantic to discuss how combination products are regulated by the FDA. We will explain entities involved and describe how you can approach them, where precedent can be found and what guidance is available to you.
At the end of this webinar, you know where to start with building the file for your drug device combination product.
This training is brought to you by the Dutch companies Holland Innovative, experts in medical device development, and Interdos, experts in medicinal product development and registration, and the German company novioneon CRO GmbH.

 

More information about the BioMan4R2 project you find on the project page.

Further information

Klick her for registration.

This training is brought to you by the Dutch companies Holland Innovative, experts in medical device development, and Interdos, experts in medicinal product development and registration, and the German company novioneon CRO GmbH.

BIoMan4R2
BioMan4R2 Euroclusters project (acronym for “BioManufacturing Eurocluster for Recovery and Resilience in EU”), funded under the COSME program, sees the need to adapt the existing funding in Health Sector for the scaling up of innovation, which can be done by creating funding mechanisms for every step of innovation process and supporting SMEs that can take leadership in biomanufacturing and medical products. The direct objective of BioMan4R2 is to establish, develop and support long-term collaboration on the EU-level between the SMEs, investors, research, clinical and knowledge organizations, science and technology parks and other companies in biomanufacturing and medtech industries through establishing an Eurocluster and launching a targeted SME Support Programme.
The partner regions in Europe for this project are LifetecZONe (NL), Turku Science Park Oy Ab (FI), Bioregio STERN (DE), Medicen Paris Region (FR), GAPR the Upper Silesian Accelerator for Commercial Enterprises Ltd (PL), Council of European Bioregions and Biocat (ES).

Follow BioMan4R2 on LinkedIN for more news and opportunities!